Repopulation of B-lymphocytes with restricted gene expression using haematopoietic stem cells engineered with lentiviral vectors
- 20 March 2008
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 15 (13) , 998-1006
- https://doi.org/10.1038/gt.2008.33
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- B cell depletion therapy in systemic lupus erythematosus: long-term follow-up and predictors of responseAnnals of the Rheumatic Diseases, 2007
- The Inflammatory Cytokine Tumor Necrosis Factor-α Generates an Autocrine Tumor-Promoting Network in Epithelial Ovarian Cancer CellsCancer Research, 2007
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- CD154 Gene Therapy for Human B-Cell MalignanciesAnnals of the New York Academy of Sciences, 2005
- B lymphocyte signaling pathways in systemic autoimmunity: Implications for pathogenesis and treatmentArthritis & Rheumatism, 2004
- B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory elementGene Therapy, 2004
- Immunopathology and the gene therapy of lupusGene Therapy, 2003
- RituximabDrugs, 2003
- Promoter suppression in cultured mammalian cells can be blocked by the chicken β-globin chromatin insulator 5′HS4 and matrix/scaffold attachment regionsJournal of Molecular Biology, 2001
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985